figshare
Browse

File(s) under permanent embargo

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Version 2 2024-06-04, 03:15
Version 1 2021-10-20, 16:28
journal contribution
posted on 2024-06-04, 03:15 authored by EA Bohula, BM Scirica, SE Inzucchi, DK McGuire, AC Keech, SR Smith, E Kanevsky, SA Murphy, LA Leiter, JP Dwyer, R Corbalan, C Hamm, L Kaplan, JC Nicolau, TO Ophuis, KK Ray, M Ruda, J Spinar, T Patel, W Miao, C Perdomo, B Francis, S Dhadda, MP Bonaca, CT Ruff, MS Sabatine, SD Wiviott, S Inzucchi, A Satlin, C Brown, A Budaj, J Dwyer, A Garcia-Castillo, M Gupta, T Oude Ophuis, K Ray, N Weissman, HD White, J Amerena, M Arstall, D Colquhoun, R Jayasinghe, A Lee, R Lehman, R Moses, J Proietto, P Purnell, J Waites, P Blombery, D Cross, M Worthley, M d'Emden, J Selvanayagam, RE Oqueli, A Whelan, P Garrahy, F de Looze, D Ninio, J Horowitz, M William, M Suranyi, G Wittert, M Le May, AS Pandey, S Vizel, R Labonte, Y Beaudry, C Fortin, A Bell, S Kouz, St-Amour, I Bata, F St Maurice, R Chehayeb, C Constance, G Wong, A Hess, J Liutkus, P Poirier, I Teitelbaum, J Berlingieri, J Cha, M Hartleib, M Heffernan, D Twum-Barima, V Pandith, R Aronson, R Goldenberg, B Ajala, A Jain, S Ross, H Bajaj, H Khandwala, Z Yared, N Gupta, J Bédard, S Wharton, F Blouin, D Savard, D Shukla
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

History

Journal

The Lancet

Volume

392

Pagination

2269-2279

Location

London, Eng.

ISSN

0140-6736

eISSN

1474-547X

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Issue

10161

Publisher

The Lancet Publishing Group

Usage metrics

    Research Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC